Document Type

Article

Language

eng

Publication Date

4-2018

Publisher

Elsevier

Source Publication

Diagnostic Microbiology and Infectious Disease

Source ISSN

0732-8893

Abstract

Meropenem–vaborbactam is a carbapenem/cyclic boronic acid β-lactamase inhibitor combination primarily active against Gram-negative bacilli, including those harboring class A serine carbapenemases such as Klebsiella pneumoniae carbapenemase (KPC). A Clinical and Laboratory Standards Institute M23-A4 (Tier 2) quality control study established broth microdilution and disk diffusion ranges for reference strains. Two KPC-producing K. pneumoniae ATCC strains are recommended for quality control testing.

Comments

Accepted version. Diagnostic Microbiology and Infectious Disease, Vol. 90, No. 4 (April 2018): 324-328. DOI. © 2018 Elsevier B.V. Used with permission.

Available for download on Monday, April 01, 2019

Share

COinS